Kalaris Therapeutics, Inc. (KLRS)
4.08
-0.07
(-1.69%)
USD |
NASDAQ |
Aug 24, 16:00
4.08
0.00 (0.00%)
After-Hours: 20:00
Kalaris Therapeutics 1 Year Total Returns (Daily) : 68.70% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 68.70% |
| August 20, 2026 | 60.31% |
| August 19, 2026 | 62.26% |
| August 18, 2026 | 61.20% |
| August 17, 2026 | 60.98% |
| August 14, 2026 | 79.74% |
| August 13, 2026 | 70.18% |
| August 12, 2026 | 58.23% |
| August 11, 2026 | 49.25% |
| August 10, 2026 | 47.57% |
| August 07, 2026 | 50.18% |
| August 06, 2026 | 58.71% |
| August 05, 2026 | 64.31% |
| August 04, 2026 | 67.44% |
| August 03, 2026 | 50.56% |
| July 31, 2026 | 30.97% |
| July 30, 2026 | 29.37% |
| July 29, 2026 | 26.39% |
| July 28, 2026 | 14.19% |
| July 27, 2026 | 29.71% |
| July 24, 2026 | 31.34% |
| July 23, 2026 | 41.52% |
| July 22, 2026 | 58.37% |
| July 21, 2026 | 66.94% |
| July 20, 2026 | 67.36% |
| Date | Value |
|---|---|
| July 17, 2026 | 80.99% |
| July 16, 2026 | 87.40% |
| July 15, 2026 | 100.8% |
| July 14, 2026 | 74.33% |
| July 13, 2026 | 81.89% |
| July 10, 2026 | 77.60% |
| July 09, 2026 | 76.08% |
| July 08, 2026 | 82.56% |
| July 07, 2026 | 85.06% |
| July 06, 2026 | 86.00% |
| July 02, 2026 | 85.55% |
| July 01, 2026 | 75.58% |
| June 30, 2026 | 52.43% |
| June 29, 2026 | 60.88% |
| June 26, 2026 | 68.75% |
| June 25, 2026 | 65.38% |
| June 24, 2026 | 76.71% |
| June 23, 2026 | 89.41% |
| June 22, 2026 | 83.33% |
| June 18, 2026 | 83.66% |
| June 17, 2026 | 77.73% |
| June 16, 2026 | 63.67% |
| June 15, 2026 | 61.74% |
| June 12, 2026 | 56.88% |
| June 11, 2026 | 50.34% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Replimune Group, Inc. | 163.8% |
| Arrowhead Pharmaceuticals, Inc. | 319.8% |
| Oncolytics Biotech, Inc. | -16.52% |
| Sangamo Therapeutics, Inc. | -75.17% |
| Sarepta Therapeutics, Inc. | -6.33% |